Skip to content

Clinical trials

Phase 1 Carcinoma, Ovarian Epithelial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 1 Country / region: United States Clear all

152 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200110
20023
20038
200412
20054
20065
20076
20083
20094
20105
20112
20126
20134
20142
20153
20164
20173
20193
20203
20217
20229
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed110
Terminated22
Recruiting8
Active, not recruiting5
Unknown status3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
Memorial Sloan Kettering Cancer Center9
Gynecologic Oncology Group7
University of Washington6
Ludwig Institute for Cancer Research5
Case Comprehensive Cancer Center4
City of Hope Medical Center4
Fred Hutchinson Cancer Center3
National Institutes of Health Clinical Center (CC)3
Regeneron Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial152
Ovarian Neoplasms74
Fallopian Tube Neoplasms61
Breast Neoplasms44
Carcinoma, Non-Small-Cell Lung38
Pancreatic Neoplasms27
Stomach Neoplasms27
Endometrial Neoplasms26
Prostatic Neoplasms25
Neoplasms23

Trials

Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.

52 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.